Hemant Surgical Industries Limited (BOM:543916)
India · Delayed Price · Currency is INR 610.50
+1.10 (0.18%)
At close: Oct 1, 2026
BOM:543916 Ratios and Metrics
Market cap in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Total Valuation
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
| 8,875 | 2,836 | 1,040 | 1,390 | - | - | |
Market Cap Growth | 117.82% | 172.59% | -25.16% | - | - | - |
Enterprise Value | 8,933 | 2,631 | 1,107 | 1,377 | - | - |
Last Close Price | 610.50 | 217.50 | 99.65 | 133.15 | - | - |
Price Ratios
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
PE Ratio | 40.86 | 15.59 | 12.94 | 14.19 | - | - |
PS Ratio | 3.83 | 1.22 | 0.98 | 1.32 | - | - |
PB Ratio | 6.45 | 2.06 | 1.65 | 2.53 | - | - |
P/TBV Ratio | 6.45 | 2.06 | 1.65 | 2.53 | - | - |
P/OCF Ratio | - | - | 22.47 | - | - | - |
EV Ratios
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
EV/Sales Ratio | 3.85 | 1.14 | 1.04 | 1.30 | - | - |
EV/EBITDA Ratio | 35.46 | 10.44 | 9.48 | 13.15 | - | - |
EV/EBIT Ratio | 37.76 | 11.12 | 10.80 | 14.58 | - | - |
Financial Efficiency
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Debt / Equity Ratio | 0.36 | 0.36 | 0.49 | 0.12 | 0.31 | 0.74 |
Debt / EBITDA Ratio | 1.97 | 1.97 | 2.66 | 0.64 | 0.67 | 1.55 |
Debt / FCF Ratio | - | - | - | - | 3.01 | 0.84 |
Net Debt / Equity Ratio | 0.04 | 0.04 | 0.34 | -0.12 | -0.06 | 0.30 |
Net Debt / EBITDA Ratio | 0.23 | 0.23 | 1.84 | -0.61 | -0.13 | 0.62 |
Net Debt / FCF Ratio | -0.14 | -0.14 | -0.65 | 0.49 | -0.56 | 0.34 |
Asset Turnover | 1.10 | 1.10 | 0.87 | 1.31 | 1.83 | 2.13 |
Inventory Turnover | 3.51 | 3.51 | 2.38 | 4.36 | 5.90 | 5.96 |
Quick Ratio | 0.85 | 0.85 | 0.49 | 0.93 | 0.68 | 0.58 |
Current Ratio | 1.45 | 1.45 | 1.45 | 1.83 | 1.24 | 1.02 |
Return on Equity (ROE) | 18.12% | 18.12% | 13.63% | 25.06% | 41.84% | 40.24% |
Return on Assets (ROA) | 7.00% | 7.00% | 5.23% | 7.32% | 10.21% | 7.13% |
Return on Invested Capital (ROIC) | 12.72% | 16.00% | 11.83% | 20.55% | 37.78% | 21.06% |
Return on Capital Employed (ROCE) | 16.80% | 16.80% | 11.80% | 16.10% | 36.00% | 31.90% |
Yields
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Earnings Yield | 2.05% | 6.42% | 7.73% | 7.05% | - | - |
FCF Yield | -4.67% | -14.61% | -31.66% | -9.41% | - | - |
Buyback Yield / Dilution | -16.59% | -16.59% | -4.93% | -33.66% | -44.60% | - |